Literature DB >> 30460524

Intracerebroventricular injection of resveratrol ameliorated Aβ-induced learning and cognitive decline in mice.

Yu Qi1, Lei Shang2, Zhengzheng Liao1, Hang Su1, Huiting Jing1, Bo Wu1, Kaishun Bi3, Ying Jia4.   

Abstract

Resveratrol (RSV) is a natural plant polyphenol compound which consists in red grape skins and wine in general. Plenty of previous studies have shown that resveratrol has neuroprotective effects. The primary object of this research was to study the effects of RSV on improving the cognitive function and neurodegeneration in the mouse model of Alzheimer's disease induced by Aβ1-42, and the possible mechanism about targeting on Sirt1, which results in attenuating inflammatory response and mitochondrial dysfunction. We established the AD model of intracerebroventricular (i.c.v.) injection of Aβ1-42 and it was observed that the significant decrease in alternately of Y Maze and the quadrant dwell time percentage of Morris water maze test. Furthermore, there were significant upregulations of AMPK/ PGC-1α and downregulations of NF-κB/ IL-1β/ NLRP3 signaling pathways in the hippocampus and prefrontal cortex in AD mice. The treatments with RSV and Donepezil could significantly ameliorate all the behavioral and biochemical changes induced by Aβ1-42. It also noticeably improved the histopathological changes in the hippocampus and cortex. The results suggested that RSV might protect against cognitive deficits and neurodegeneration induced by Aβ1-42, and serve as a potential agent in treatment of AD.

Entities:  

Keywords:  Alzheimer’s disease; Inflammation; Intracerebroventricular injection; Mitochondrial dysfunction; Resveratrol; Sirt1

Mesh:

Substances:

Year:  2018        PMID: 30460524     DOI: 10.1007/s11011-018-0348-6

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  15 in total

1.  NLRP3 inflammasome as a novel therapeutic target for heart failure.

Authors:  Shuangcui Wang; Jiaqi Zhang; Yuli Wang; Xijuan Jiang; Maojuan Guo; Zhen Yang
Journal:  Anatol J Cardiol       Date:  2022-01       Impact factor: 1.596

2.  Resveratrol Inhibits NLRP3 Inflammasome-Induced Pyroptosis and miR-155 Expression in Microglia Through Sirt1/AMPK Pathway.

Authors:  Kemal Ugur Tufekci; Bedir Irem Eltutan; Kamer Burak Isci; Sermin Genc
Journal:  Neurotox Res       Date:  2021-11-05       Impact factor: 3.911

3.  Effects of Resveratrol Supplementation on the Cognitive Function of Patients with Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials.

Authors:  Jéssica Abdo Gonçalves Tosatti; Adriana Fialho da Silva Fontes; Paulo Caramelli; Karina Braga Gomes
Journal:  Drugs Aging       Date:  2022-02-21       Impact factor: 4.271

Review 4.  Dietary Supplements for COVID-19.

Authors:  Gerard E Mullin; Berkeley Limektkai; Lin Wang; Patrick Hanaway; Loren Marks; Edward Giovannucci
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Resveratrol, Metabolic Dysregulation, and Alzheimer's Disease: Considerations for Neurogenerative Disease.

Authors:  Alex J T Yang; Ahmed Bagit; Rebecca E K MacPherson
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 6.  Inhibitory activities of grape bioactive compounds against enzymes linked with human diseases.

Authors:  Vagish Dwibedi; Sahil Jain; Divya Singhal; Anuradha Mittal; Santosh Kumar Rath; Sanjai Saxena
Journal:  Appl Microbiol Biotechnol       Date:  2022-02-02       Impact factor: 4.813

7.  Neuroprotective Properties of Resveratrol and Its Derivatives-Influence on Potential Mechanisms Leading to the Development of Alzheimer's Disease.

Authors:  Michał Wiciński; Anna Domanowska; Eryk Wódkiewicz; Bartosz Malinowski
Journal:  Int J Mol Sci       Date:  2020-04-15       Impact factor: 5.923

Review 8.  Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases.

Authors:  Carolina Pellegrini; Matteo Fornai; Luca Antonioli; Corrado Blandizzi; Vincenzo Calderone
Journal:  Int J Mol Sci       Date:  2019-06-13       Impact factor: 5.923

Review 9.  Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer's disease: flavonoids and phenols.

Authors:  Meng Zhang; Guanhua Hu; Nan Shao; Yunpeng Qin; Qian Chen; Yan Wang; Peng Zhou; Biao Cai
Journal:  Inflammopharmacology       Date:  2021-08-04       Impact factor: 4.473

Review 10.  The Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases.

Authors:  Fangzhou Jiao; Zuojiong Gong
Journal:  Oxid Med Cell Longev       Date:  2020-09-14       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.